ARDS
-
Warrington’s Windtree Therapeutics Succeeds in Trial of COVID-Related Lung Distress Treatment
A Phase 2 test by Windtree Therapeutics of its drug treatment for Associated Acute Respiratory Distress Syndrome (ARDS) may hold hope for patients with damaged…
























